IRD vs PHM · rev $11.0M vs P/E 7.7, rev $17.95B
Opus Genetics, Inc. (IRD) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
IRD currently screens at market cap $35.7M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the IRD and PHM stock pages for the full models.
Not investment advice.